HIV Prevention Studies

Since its establishment in 1987, hundreds of HIV-negative have participated in clinical trials at the Case ACTU. Their participation led directly to crucial HIV-prevention research. Many of the clinical trials offered at the Case ACTU are through its affiliation with the HIV Vaccine Trials Network ( and the HIV Prevention Trials Network ( At any given point in time, the Case ACTU has several trials enrolling HIV-negative people for a variety of prevention methods.

To receive more information or for questions regarding AIDS clinical trials at Case Medical Center, call 216-844-4444 or email .

HVTN116 The Case Western Reserve Clinical Trials Unit is currently enrolling healthy, HIV-negative women and men, ages 18-50, in an HIV prevention vaccine trial, sponsored by the National Institutes of Health.  The study is enrolling 101 participants in 5 cities.  This trial is not asking whether the vaccines work as […]

Vaccine Study Enrolling HIV-Negative Men & Women

A Phase 2B clinical trial to evaluate the safety and drug levels of a human monoclonal antibody (VRC01) administered in multiple doses intravenously and subcutaneously in different dosing schedules to healthy, HIV-uninfected adults. This strategy is called passive immunization, or antibody-mediated prevention (AMP).   Purpose of the Study Primary objective 1: To evaluate the […]

AMP Study: A Passive Immunization Clinical Trial for HIV-Negative Adults